---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-147017"
form_type: "8-K"
ticker: "PHAT"
cik: "0001783183"
company_name: "Phathom Pharmaceuticals, Inc."
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:47:40.332890+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Phathom stockholders elect three Class II directors; ratify E&Y as auditor

## Summary
- Elected Cola (24.1M for), Karbe (25.0M for), Parikh (21.3M for) with 10.8M broker non-votes each.
- Ratified Ernst & Young as independent auditor for fiscal 2024: 37.9M for, 124.6K against, 1.1K abstain.
- New non-employee directors get initial grant of 21,000 RSUs and options to purchase 35,000 shares.
- Annual director equity grant set at 10,500 RSUs and options for 17,500 shares; cash retainers unchanged.

## SEC filing metadata
- accession: 0001193125-24-147017
- form_type: 8-K
- ticker: PHAT
- cik: 0001783183
- company_name: Phathom Pharmaceuticals, Inc.
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783183/000119312524147017/0001193125-24-147017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783183/000119312524147017/d810940d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-147017
- JSON: https://secwatch.observer/filing/0001193125-24-147017.json
- Plain text: https://secwatch.observer/filing/0001193125-24-147017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.